GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Ashland Inc (NYSE:ASH) » Definitions » Total Liabilities

ASH (Ashland) Total Liabilities : $2,674 Mil (As of Mar. 2025)


View and export this data going back to 1950. Start your Free Trial

What is Ashland Total Liabilities?

Ashland's Total Liabilities for the quarter that ended in Mar. 2025 was $2,674 Mil.

Ashland's quarterly Total Liabilities declined from Sep. 2024 ($2,777.00 Mil) to Dec. 2024 ($2,639.00 Mil) but then increased from Dec. 2024 ($2,639.00 Mil) to Mar. 2025 ($2,674.00 Mil).

Ashland's annual Total Liabilities declined from Sep. 2022 ($2,993.00 Mil) to Sep. 2023 ($2,842.00 Mil) and declined from Sep. 2023 ($2,842.00 Mil) to Sep. 2024 ($2,777.00 Mil).


Ashland Total Liabilities Historical Data

The historical data trend for Ashland's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ashland Total Liabilities Chart

Ashland Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,841.00 3,860.00 2,993.00 2,842.00 2,777.00

Ashland Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,814.00 2,780.00 2,777.00 2,639.00 2,674.00

Ashland Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ashland's Total Liabilities for the fiscal year that ended in Sep. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=490+(1448+603
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+57+110+69)
=2,777

Total Liabilities=Total Assets (A: Sep. 2024 )-Total Equity (A: Sep. 2024 )
=5645-2868
=2,777

Ashland's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=463+(1418+654
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+29+110+69)
=2,674

Total Liabilities=Total Assets (Q: Mar. 2025 )-Total Equity (Q: Mar. 2025 )
=5233-2559
=2,674

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ashland Total Liabilities Related Terms

Thank you for viewing the detailed overview of Ashland's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Ashland Business Description

Traded in Other Exchanges
Address
8145 Blazer Drive, Wilmington, DE, USA, 19808
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.
Executives
Guillermo Novo director, officer: Chairman and CEO AIR PRODUCTS AND CHEMICALS, INC., 7201 HAMILTON BOULEVARD, ALLENTOWN PA 18195
Eric N Boni officer: Principal Accounting Officer 8145 BLAZER DRIVE, WILMINGTON DE 19808
Robin E. Lampkin officer: SVP, Gen. Counsel & Secretary 5475 RINGS ROAD, NORTH TOWER, 5TH FLOOR, DUBLIN OH 43017
J Kevin Willis officer: Chief Financial Officer 50 E RIVERCENTER BLVD, COVINGTON KY 41011
James P. Minicucci officer: SVP Strategy, M&A & Portfolio 5474 RINGS ROAD, NORTH TOWER, 5TH FLOOR, DUBLIN OH 43017
Karl R. Bostaph officer: SVP Operations 5474 RINGS ROAD, NORTH TOWER, 5TH FLOOR, DUBLIN OH 43017
Sergio Pedreiro director 2 PARK AVENUE, NEW YORK NY 10016
Eileen Drury officer: SVP and Chief Human Resources 8145 BLAZER DRIVE, WILMINGTON DE 19808
Ricky C Sandler director, other: See Remarks 65 EAST 55TH STREET, 25TH FLOOR, NEW YORK NY 10022
Steven D Bishop director ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
Suzan F. Harrison director 77 WEST WACKER DRIVE, SUITE 4600, CHICAGO IL 60601
Winkler Von Mohrenfels Petra Yvonne officer: Sr. VP, GC and Secretary 8145 BLAZER DRIVE, WILMINGTON DE 19808
Min Chong officer: Sr VP & Gen Mgr, Spc Additives 8145 BLAZER DRIVE, WILMINGTON DE 19808
Osama M Musa officer: Sr. Vice President ASHLAND GLOBAL HOLDINGS INC, 1005 ROUTE 202/206, BRIDGEWATER NJ 08807
Swaminathan Ashok Kalyana officer: Sr VP & Gen Mgr, Life Sciences 8145 BLAZER DRIVE, WILMINGTON DE 19808